Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study.

Florian KurtzFlorian StrullerPhilipp HorvathWiebke SolassHans BösmüllerAlfred KönigsrainerMarc André Reymond

Published in: Gastroenterology research and practice (2018)

PIPAC is feasible, safe, and well-tolerated and can induce histological regression in a significant proportion of pretreated PM patients. This trial is registered with NCT03210298.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
air pollution
particulate matter
study protocol
randomized controlled trial
squamous cell carcinoma
locally advanced
water soluble
risk assessment
polycyclic aromatic hydrocarbons